Jun 30, 2026 Masahiro Morimoto, President & CEO of FRONTEO, Delivers a Lecture at American University in Washington, D.C. Highlights the Value of Human-Centered AI and the Competitive Advantage of “KIBIT” in Supporting Scientific Discovery
May 28, 2026 FRONTEO and SCOHIA PHARMA Sign Agreement to Explore New Indications Using the AI Drug Discovery Support Service “DDAIF”
May 13, 2026 The University of Oklahoma confirms inhibition of cell proliferation with a novel candidate target molecule for pancreatic cancer discovered by FRONTEO's AI drug discovery support service, Drug Discovery AI Factory Aiming to develop drugs that meet unmet medical needs by advancing to animal testing in the future
May 13, 2026 FRONTEO Opens KIBIT AI Biology Lab, a Center for AI Drug Discovery Major update of the AI drug discovery support service Drug Discovery AI Factory and full-scale operation of the system that handles the upstream of the drug discovery value chain
Apr 23, 2026 Genenet Implements FRONTEO’s Medical Paper Search AI System “KIBIT Amanogawa” to Identify Anti-Aging Compounds in Industrial Waste and Plants Trial Utilizing Fukuoka Prefecture Subsidy Program Yields Positive Results
Apr 16, 2026 FRONTEO and Astellas Pharma Sign Agreement for Target Molecule Discovery “Drug Discovery AI Factory,” AI-based drug discovery support service, enables discontinuous discovery of new target molecules, paving the way for the early creation of innovative pharmaceuticals
Mar 31, 2026 FRONTEO and Keio University School of Medicine Have Been Granted Two Patents for a Conversational AI Program to Support Depression Diagnosis The system assesses depressive symptoms based on approximately 10 minutes of free conversation; designed for use in a variety of medical and healthcare settings, including telemedicine and health screenings, it aims to address the treatment gap.
Mar 26, 2026 TalkLab KIBIT,” a web application that uses AI analysis to assess “Brain Health Score” through conversation, has launched as part of Asahi Life Insurance's “Everyone's Peace of Mind 100-Year Project.”
Mar 5, 2026 FRONTEO Expands Reach of “Brain Health Score” Through Local Government Partnerships; Offers Hands-On Experience with “TalkLab KIBIT” in Gamagori City
Feb 12, 2026 FRONTEO Launches “DDAIF Innovation Bridge” to Provide Scientific Support for Bio-Ventures Through Its AI-Driven Drug Discovery Support Service “Drug Discovery AI Factory”
Feb 12, 2026 FRONTEO and NB Health Laboratory Reach a Basic Agreement on Joint Research in GPCR Antibody Drug Discovery Aiming for implementation as early as FY2026 to secure discontinuous revenue opportunities
Feb 5, 2026 FRONTEO and GlyTech Launch Proof-of-Concept (PoC) for AI-Driven Drug Discovery Utilizing Drug Discovery AI Factory—which systematically identifies previously unknown correlations between diseases and target molecules based on existing literature—to explore new target molecules and indications for glycan-modification-based drug discovery